AccelBio participated in BioEurope event in Munich from November 6th to 8th, actively advancing the frontiers of biotech. With a commitment to advancing the boundaries of biotech, AccelBio strategically utilized the event to explore synergies with industry leaders, investors, and potential partners.
At the conference, AccelBio unveiled its cutting-edge Organoids platform, presenting a pivotal opportunity to forge partnerships that will expedite the development and commercialization of groundbreaking medicines.